Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
2,105
Views
3
CrossRef citations to date
0
Altmetric
Brief Report

Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes

L Marottea Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
M Capitaoa Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
C Deleinea Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
T Beauvaisb LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France;c Université De Nantes, CNRS, INSERM, CRCINA, CHU of Nantes, Nantes, FranceView further author information
,
G Cadioua Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
J. Perrina Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
M Chéreld Université De Nantes, CNRS, INSERM, CRCINA, ICO Gauducheau, Nantes, France;e LabEx IRON “Innovative Radiopharmaceuticals in Oncology and Neurology”, Nantes, France;f GIP Arronax, Saint-Herblain, FranceView further author information
,
E Scoteta Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
Y Guillouxa Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
F Bruchertseiferg European Commission, Joint Research Centre (JRC), Karlsruhe, GermanyView further author information
,
A Morgensterng European Commission, Joint Research Centre (JRC), Karlsruhe, GermanyView further author information
,
A Jarrya Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceView further author information
,
J. Gascheta Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceCorrespondence[email protected]
View further author information
&
N Labarrierea Université De Nantes, CNRS, INSERM, CRCINA, Nantes, France;b LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, FranceCorrespondence[email protected]
View further author information
 show all
Article: 1940676 | Received 28 Apr 2021, Accepted 07 Jun 2021, Published online: 27 Jun 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.